Skip to content

Alnylam Pharmaceuticals

US · ALNY #627 by market cap Listed 1970
224.41 +0.47 +0.21%
Live - 5344 symbols - heartbeat 131s ago · 2026-10-08 06:06
Pre-market 224.50 +0.04%
After-hours 224.41 0.00%
Overnight 224.32 -0.04%
Market cap
30.03B
P/B
22.17
EPS
2.33
Reader sentiment Are you bullish or bearish on ALNY?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Cantor Fitzgerald Maintains Alnylam Pharmaceuticals(ALNY.US) With Hold Rating, Cuts Target Price to $325
    Market Newswire · 2026/9/30
  • Rating change
    Bernstein Initiates Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Announces Target Price $376
    Market Newswire · 2026/8/24
  • Rating change
    Needham Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $357
    Market Newswire · 2026/9/18
  • Rating change
    Barclays Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $450
    Market Newswire · 2026/9/1
  • Rating change
    CCORF Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $429
    Market Newswire · 2026/8/3
  • Rating change
    Morgan Stanley Maintains Alnylam Pharmaceuticals(ALNY.US) With Hold Rating, Maintains Target Price $300
    Market Newswire · 2026/9/13
  • Bernstein Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $376
    Market Newswire · 2026/9/26
  • Rating change
    Truist Financial Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating
    Market Newswire · 2026/9/18
  • Rating change
    Citi Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Cuts Target Price to $340
    Market Newswire · 2026/8/3
  • Rating change
    Stifel Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $318
    Market Newswire · 2026/8/14
  • Rating change
    A Quick Look at Today's Ratings for Alnylam Pharmaceuticals(ALNY.US), With a Forecast Between $315 to $455
    Market Newswire · 2026/8/5
  • Rating change
    A Quick Look at Today's Ratings for Alnylam Pharmaceuticals(ALNY.US), With a Forecast Between $230 to $420
    Market Newswire · 2026/8/1
  • Rating change
    J.P. Morgan Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $375
    Market Newswire · 2026/8/5
  • Rating change
    BMO Capital Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $318
    Market Newswire · 2026/9/18
  • Rating change
    Evercore Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Cuts Target Price to $325
    Market Newswire · 2026/8/6
  • Rating change
    Barclays Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Cuts Target Price to $450
    Market Newswire · 2026/8/3
  • J.P. Morgan Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Cuts Target Price to $369
    Market Newswire · 2026/9/30
  • Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), AxoGen (AXGN) and Biohaven Ltd. (BHVN)
    TipRanks · 2026/9/30
  • Rating change
    A Quick Look at Today's Ratings for Alnylam Pharmaceuticals(ALNY.US), With a Forecast Between $318 to $489
    Market Newswire · 2026/9/1
  • H.C. Wainwright Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $455
    Market Newswire · 2026/9/21

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 06:06:04 · For reference only, not investment advice and not tailored to your situation.